XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of fair value, assets measured on recurring basis
  Fair Value Measurement at December 31, 2021 
   Total   Level 1   Level 2   Level 3 
Investment in term promissory note of Ault &
Company, Inc. (“Ault & Company”) and other
– a related party		  $2,842,000   $-   $-   $2,842,000 
Investment in common stock of Alzamend – a
related party		   13,230,000    13,230,000    -    - 
Investments in marketable equity securities   40,380,000    40,380,000    -    - 
Cash and marketable securities held in trust
account		   116,725,000    116,725,000    -    - 
Investments in equity securities   30,482,000    -    -    30,482,000 
Total assets measured at fair value  $203,659,000   $170,335,000   $-   $33,324,000 

 

   Fair Value Measurement at December 31, 2020 
   Total   Level 1   Level 2   Level 3 
Investments in convertible promissory notes and
advances of Alzamend – related parties		  $797,000   $-   $-   $797,000 
Investments in marketable equity securities   653,000    -    -    653,000 
Investments in marketable equity securities   2,563,000    2,563,000    -    - 
Investments in equity securities   262,000    -    -    262,000 
Total assets measured at fair value  $4,275,000   $2,563,000   $-   $1,712,000 
Schedule of investments
  Investments in 
   equity 
   securities 
Balance at January 1, 2021  $262,000 
Investment in convertible preferred stock   14,950,000 
Investment in warrants   2,673,000 
Change in fair value of warrants   8,224,000 
Conversion of loans to equity securities   3,520,000 
Unrealized gains on equity securities   2,510,000 
Conversion to marketable securities   (1,657,000)
Balance at December 31, 2021  $30,482,000